Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2052379 | 0.85 | — | — | |
| SCHEMBL2733004 | 0.85 | ALDH1A1 (0.32) | ALDH1A1MEN1POLBKMT2A | |
| SCHEMBL24195740 | 0.84 | ALDH1A1 (0.32) | ALDH1A1MEN1POLBKMT2A | |
| SCHEMBL30529276 | 0.83 | CA1 (0.30) | — | |
| SCHEMBL5698270 | 0.82 | ALDH1A1 (0.35) | ALDH1A1 | |
| SCHEMBL9178325 | 0.82 | ALDH1A1 (0.31) | ALDH1A1TSHR | |
| SCHEMBL9178328 | 0.82 | ALDH1A1 (0.31) | ALDH1A1TSHR | |
| SCHEMBL15096621 | 0.81 | — | — | |
| SCHEMBL641157 | 0.81 | ALDH1A1 (0.30) | ALDH1A1 | |
| SCHEMBL439901 | 0.81 | TSHR (0.36) | MEN1POLBKMT2ATSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 242 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12358933-B2 | Meta-POSS (meta-polyhedral oligomeric silsesquioxane) compound, a preparation method thereof, and a composition containing the meta-POSS compound prepared by the preparation method | PIOCEL CO., LTD. (KR) | 2025-07-15 | — | — | US | claimed |
| US-20250109153-A1 | A novel meta-POSS (meta-polyhedral oligomeric silsesquioxane) compound, a preparation method thereof, and a composition containing the meta-POSS compound prepared by the preparation method | PIOCEL CO., LTD. (KR) | 2025-04-03 | — | — | US | claimed |
| CN-118005838-A | Copolymer containing oxygen heterocyclic side group and application thereof | 国联汽车动力电池研究院有限责任公司 | 2024-05-10 | — | — | CN | claimed |
| WO-2023153586-A1 | NOVEL META-POLYHEDRAL OLIGOMERIC SILSESQUIOXANE (META-POSS) COMPOUND, PRODUCTION METHOD THEREFOR, AND COMPOSITION COMPRISING META-POSS COMPOUND PRODUCED THEREBY | 주식회사 파이오셀 | 2023-08-17 | — | — | WO | claimed |
| EP-1967540-B1 | CURABLE COMPOSITION | KANEKA CORP (JP) | 2013-04-03 | — | — | EP | claimed |
| US-8263725-B2 | Curable composition | KANEKA CORPORATION (JP) | 2012-09-11 | — | — | US | claimed |
| US-20100222525-A1 | CURABLE COMPOSITION | KANEKA CORPORATION (JP) | 2010-09-02 | — | — | US | claimed |
| US-7592376-B2 | Photopolymerizable epoxide and oxetane compositions | RENSSELAER POLYTECHNIC INSTITUTE (US) | 2009-09-22 | — | — | US | claimed |
| EP-1967540-A1 | CURABLE COMPOSITION | Kaneka Corporation (JP) | 2008-09-10 | — | — | EP | claimed |
| US-20060041032-A1 | Photopolymerizable epoxide and oxetane compositions | CRIVELLO JAMES V | 2006-02-23 | — | — | US | claimed |
| US-6498200-B1 | OXIRANE OR OXETANE RING COMPOUND, ORGANIC PEROXIDE, ONIUM SALT CATALYST, AND ALKALINE FILLER; CURES RAPIDLY; STABLE DOES NOT CAUSE INCREASE IN ELECTROCONDUCTIVITY OR CORROSION; SEALANT, BINDER, ENCAPSULATING AGENT, DIELECTRIC FILM | NAMICS CORPORATION (JP) | 2002-12-24 | — | — | US | claimed |
| EP-4182375-B1 | RELEASABLE COMPOSITIONS BASED ON POLYACETALS | DELO INDUSTRIE KLEBSTOFFE GMBH & CO KGAA (DE) | 2026-05-20 | — | — | EP | disclosed |
| EP-4496826-B1 | LOW-TEMPERATURE-CURING COMPOUNDS BASED ON GLYCIDYL ETHERS | DELO INDUSTRIE KLEBSTOFFE GMBH & CO KGAA (DE) | 2026-05-06 | — | — | EP | disclosed |
| US-12565560-B2 | Releasable compositions based on polyacetals | DELO INDUSTRIE KLEBSTOFFE GMBH & CO. KGAA (DE) | 2026-03-03 | — | — | US | disclosed |
| WO-2025233508-A1 | DEBONDING OF A CURED COMPOSITION | HENKEL AG & CO. KGAA (DE) | 2025-11-13 | — | — | WO | disclosed |
| JP-2000247981-A | PRODUCTION OF SILICON COMPOUND | TOAGOSEI CO LTD | 2000-09-12 | — | — | JP | disclosed |
| US-6096903-A | Hydrolysable and polymerizable oxetane silanes | IVOCLAR AG (LI) | 2000-08-01 | — | — | US | disclosed |
| EP-0867443-A2 | Hydrolyzable and polymerizable oxetanesilanes | IVOCLAR AG (LI) | 1998-09-30 | — | — | EP | disclosed |
| US-5721020-A | CATION-POLYMERIZABLE COMPOUND, COMPOUND HAVING AT LEAST ONE OXETANE RING, CATIONIC INITIATOR AND LUBRICITY-IMPARTING AGENT | KANSAI PAINT CO., LTD. (JP) | 1998-02-24 | — | — | US | disclosed |
| US-5463084-A | High speed curing; chemical resistant, strong, adherent; protective coatings,insulation | RENSSELAER POLYTECHNIC INSTITUTE (US) | 1995-10-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12565560-B2 | Releasable compositions based on polyacetals | ADH1A, ADH1C, ALDH1A1 | ALDH1A1 3/4885MEN1 3217/4885POLB 2632/4885 |
| US-12358933-B2 | Meta-POSS (meta-polyhedral oligomeric silsesquioxane) compound, a preparation method thereof, and a composition containing the meta-POSS compound prepared by the preparation method | SPEN, SAE1, OSTC | ALDH1A1 4639/4885MEN1 188/4885POLB 925/4885 |
| US-20250109153-A1 | A novel meta-POSS (meta-polyhedral oligomeric silsesquioxane) compound, a preparation method thereof, and a composition containing the meta-POSS compound prepared by the preparation method | SPEN, SAE1, SOST | ALDH1A1 4652/4885MEN1 196/4885POLB 830/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.